Skip to main content
. 2014 May 20;9(5):e97419. doi: 10.1371/journal.pone.0097419

Figure 5. Serum levels and the % inhibition of AST and ALT in TAA-induced acute hepatic damage.

Figure 5

A) Serum AST levels. * P<0.001 compared with group A (control). B) Serum ALT levels * P<0.0001 compared with group A (control). # P<0.01 compared with group C (acute hepatic damage). C) The % inhibition of TAA-induced increase of serum AST levels between group D (acute hepatic damage with lansoprazole) and group F (acute hepatic damage with lansoprazole and SnMP). D) The % inhibition of TAA-induced increase of serum ALT levels between group D (acute hepatic damage with lansoprazole) and group F (acute hepatic damage with lansoprazole and SnMP).